Another Major Trial Challenges Axillary Dissection Practice

Another Major Trial Challenges Axillary Dissection Practice

IBCSG Trial 23-01
A randomized trial of axillary dissection vs. no axillary dissection for patients with clinically node negative breast cancer and micrometastases in the sentinel node


 In certain women with early-stage breast cancer and positive nodes, sentinel lymph node dissection (SLND) does not result in inferior survival, compared with axillary lymph node dissection (ALND)
The women in the study all had clinical T1/T2 invasive breast cancer and 1 or 2 sentinel lymph nodes (SLNs).